<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>207(6)</volume><submitter>Liu Q</submitter><funding>The present study was supported by National Natural Science Foundation of China</funding><funding>Young Clinical Talents Training Program of Chinese Society of Traditional Chinese Medicine</funding><funding>Project of Academic Inheritance Studio of Famous and Aged Chinese Medicine Experts in Zhejiang Province</funding><funding>Clinical Medical Research Project of Zhejiang Medical Association</funding><journal>British journal of haematology</journal><pagination>2617-2621</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12710174</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial.</pubmed_title><pmcid>PMC12710174</pmcid><funding_grant_id>CYJH2024043</funding_grant_id><funding_grant_id>82174138</funding_grant_id><funding_grant_id>GZS2021022</funding_grant_id><funding_grant_id>2022ZYC-Z25</funding_grant_id><pubmed_authors>Xu L</pubmed_authors><pubmed_authors>Zhou M</pubmed_authors><pubmed_authors>Xia Y</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Rong C</pubmed_authors><pubmed_authors>Dong X</pubmed_authors><pubmed_authors>Zhou P</pubmed_authors><pubmed_authors>Qiu D</pubmed_authors><pubmed_authors>Ye B</pubmed_authors><pubmed_authors>Cai J</pubmed_authors><pubmed_authors>Shou L</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Wu D</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Hu H</pubmed_authors><pubmed_authors>Shen Y</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reduced dose prednisone plus eltrombopag for the treatment of newly diagnosed adult primary immune thrombocytopenia: A prospective, multicentre, phase 2 clinical trial.</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T04:13:02.786Z</modification><creation>2026-05-25T03:12:03.048Z</creation></dates><accession>S-EPMC12710174</accession><cross_references><pubmed>40954566</pubmed><doi>10.1111/bjh.70168</doi></cross_references></HashMap>